KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Adaptive Biotechnologies (ADPT) Amortization - Intangibles (2018 - 2025)

Adaptive Biotechnologies' Amortization - Intangibles history spans 8 years, with the latest figure at $429000.0 for Q4 2025.

  • For Q4 2025, Amortization - Intangibles changed 0.23% year-over-year to $429000.0; the TTM value through Dec 2025 reached $1.7 million, changed 0.23%, while the annual FY2025 figure was $1.7 million, 0.23% changed from the prior year.
  • Amortization - Intangibles for Q4 2025 was $429000.0 at Adaptive Biotechnologies, roughly flat from $428000.0 in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $429000.0 in Q4 2021 and bottomed at $419000.0 in Q1 2021.
  • The 5-year median for Amortization - Intangibles is $426000.0 (2021), against an average of $424950.0.
  • The largest annual shift saw Amortization - Intangibles dropped 1.18% in 2021 before it increased 0.95% in 2024.
  • A 5-year view of Amortization - Intangibles shows it stood at $429000.0 in 2021, then changed by 0.0% to $429000.0 in 2022, then changed by 0.0% to $429000.0 in 2023, then dropped by 0.23% to $428000.0 in 2024, then rose by 0.23% to $429000.0 in 2025.
  • Per Business Quant, the three most recent readings for ADPT's Amortization - Intangibles are $429000.0 (Q4 2025), $428000.0 (Q3 2025), and $423000.0 (Q2 2025).